Selection bias, investment decisions and treatment effect distributions

por Wiklund, Stig Johan, Burman, Carl‐Fredrik
Publicado 2021

A modified weighted log-rank test for confirmatory trials with a high proportion of treatment switching

por Jiménez, José L., Niewczas, Julia, Bore, Alexander, Burman, Carl-Fredrik
Publicado 2021

Estimands and Complex Innovative Designs

por Collignon, Olivier, Schiel, Anja, Burman, Carl‐Fredrik, Rufibach, Kaspar, Posch, Martin, Bretz, Frank
Publicado 2022

Optimizing Trial Designs for Targeted Therapies

por Ondra, Thomas, Jobjörnsson, Sebastian, Beckman, Robert A., Burman, Carl-Fredrik, König, Franz, Stallard, Nigel, Posch, Martin
Publicado 2016

Optimized adaptive enrichment designs

por Ondra, Thomas, Jobjörnsson, Sebastian, Beckman, Robert A, Burman, Carl-Fredrik, König, Franz, Stallard, Nigel, Posch, Martin
Publicado 2017

Lessons learned from IDeAl — 33 recommendations from the IDeAl-net about design and analysis of small population clinical trials

por Hilgers, Ralf-Dieter, Bogdan, Malgorzata, Burman, Carl-Fredrik, Dette, Holger, Karlsson, Mats, König, Franz, Male, Christoph, Mentré, France, Molenberghs, Geert, Senn, Stephen
Publicado 2018

On model-based time trend adjustments in platform trials with non-concurrent controls

por Roig, Marta Bofill, Krotka, Pavla, Burman, Carl-Fredrik, Glimm, Ekkehard, Gold, Stefan M., Hees, Katharina, Jacko, Peter, Koenig, Franz, Magirr, Dominic, Mesenbrink, Peter, Viele, Kert, Posch, Martin
Publicado 2022

A framework for assessing the impact of accelerated approval

por Gould, A. Lawrence, Campbell, Robert K., Loewy, John W., Beckman, Robert A., Dey, Jyotirmoy, Schiel, Anja, Burman, Carl-Fredrik, Zhou, Joey, Antonijevic, Zoran, Miller, Eva R., Tang, Rui
Publicado 2022